Skip to main content
Equibles

EVAX · Evaxion A/S · Webcasts, Transcripts & Audio

Track EVAX — free

Use EVAX with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research EVAX.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$3.15 -0.05 (-1.56%) At close · Oct 5
Rebalance outlook locked
Market Cap
$28.42M
Shares
9.02M
Volume · Oct 5 38.24K Avg daily vol (3M) 196.3K

Evaxion A/S Webcasts

Earnings calls, investor updates, investor days and conferences for Evaxion A/S (EVAX), with available transcripts, audio replays and slides. Earnings calls also include available highlights, earnings releases and periodic filings.

Pull transcripts and briefs through the earnings call transcript API or MCP →

Revenue & result across quarters

Revenue Net income YoY up YoY down artefacts
· $ −$5.68M '23 Q2 23-06-30 · $154,000 −$6.20M '24 Q2 24-06-30 LATEST ▼76% $37,000 −$4.83M '25 Q2 25-06-30
Earnings call
FY26 · Q2
2026-08-20
Evaxion A/S (EVAX) Q2 2026 Earnings Call Transcript
Confident tone EVX-01 personalized cancer vaccine in melanoma AI immunology platform validation Financial discipline and cash runway
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY26 · Q1
2026-03-31
Evaxion A/S (EVAX) Q1 2026 Earnings Call Transcript
Positive tone EVX-01 melanoma Phase II program AI-Immunology platform expansion Business development and partnering
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q4
2025-12-31
Evaxion A/S (EVAX) Q4 2025 Earnings Call Transcript
Confident tone AI immunology platform expansion into autoimmune disease Business development and MSD partnership EVX-01 personalized cancer vaccine Phase II data
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY25 · Q3
2025-09-30
Evaxion A/S (EVAX) Q3 2025 Earnings Call Transcript
Confident tone EVX-01 Phase II clinical data (ESMO) MSD partnership and EVX-B3 in-licensing Leadership transition
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q2
2025-06-30
Evaxion A/S (EVAX) Q2 2025 Earnings Call Transcript
Positive tone EVX-01 Phase II melanoma program Infectious disease pipeline expansion EIB loan conversion to equity
Revenue
$37,000
▼ 76% YoY
Rev · 3q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q1
2025-03-31
Evaxion A/S (EVAX) Q1 2025 Earnings Call Transcript
Confident tone EVX-01 clinical program Business development and partnerships Financial results and derivatives
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q2
2024-06-30
Evaxion A/S (EVAX) Q2 2024 Earnings Call Transcript
Confident tone EVX-01 Phase 2 in melanoma Pipeline and upcoming milestones Business development and partnerships
Revenue
$154,000
Rev · 2q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q4
2023-12-31
Evaxion A/S (EVAX) Q4 2023 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY23 · Q2
2023-06-30
Evaxion A/S (EVAX) Q2 2023 Earnings Call Transcript
Revenue
$
Diluted EPS
$-10.50
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q4
2022-12-31
Evaxion A/S (EVAX) Q4 2022 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY22 · Q2
2022-06-30
Evaxion A/S (EVAX) Q2 2022 Earnings Call Transcript
Diluted EPS
$-10.00
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q1
2022-03-31
Evaxion A/S (EVAX) Q1 2022 Earnings Call Transcript
Diluted EPS
$-12.50
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q4
2021-12-31
Evaxion A/S (EVAX) Q4 2021 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY21 · Q1
2021-03-31
Evaxion A/S (EVAX) Q1 2021 Earnings Call Transcript
Diluted EPS
$-11.50
Audio Transcript Slides 8-K10-Q
Showing 1–14 of 14 webcasts
Key facts CIK 1828253 CUSIP 29970R303 Visit website Investor relations